In contrast, in Mdr2 (Abcb4) deficient mice with sclerosing cholangitis, a low dose of IL-2 treatment diminishes biliary injury and fibrosis by the expansion of intrahepatic Tregs (44). This evidence concerns the gene ABCB4 and sclerosing cholangitis.